XML 27 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Shareholders' Deficit (Unaudited) (June 2019) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, value at Dec. 31, 2016 $ 0 $ 0 $ (2,066,785) $ (1,324,472)
Stock Based Compensation   84,837   84,837
Net loss for period     (2,577,395) (2,577,395)
Ending balance, shares at Dec. 31, 2017 25,046,000      
Ending balance, value at Dec. 31, 2017 $ 25,036 3,258,116 (4,644,180) (1,361,028)
Clawback of stock granted, shares (375,000)      
Clawback of stock granted, value $ (375) 375    
Payment of outstanding balance of PPM   80,000   80,000
Stock Based Compensation   213,955   213,955
Stock Grant Program Vesting, shares 37,000      
Stock Grant Program Vesting, value $ 137 (137)   0
Warrants issued related to debt revisions/Warrant Issuance Related to Convertible Debentures/   4,525   4,525
Payment of accrued bonus, shares 100,000      
Payment of accrued bonus, value $ 10 99,990   100,000
Net loss for period     (1,281,698) (1,281,698)
Ending balance, shares at Jun. 30, 2018 24,808,000      
Ending balance, value at Jun. 30, 2018 $ 24,808 3,656,284 (5,925,878) (2,244,246)
Beginning balance, shares at Dec. 31, 2017 25,046,000      
Beginning balance, value at Dec. 31, 2017 $ 25,036 3,258,116 (4,644,180) (1,361,028)
Clawback of stock granted, shares (375,000)      
Clawback of stock granted, value $ (375) 375    
Payment of outstanding balance of PPM   80,000   80,000
Stock Based Compensation   1,345,825   1,345,825
Warrants issued related to debt revisions/Warrant Issuance Related to Convertible Debentures/   4,525   4,525
Net loss for period     (3,895,873) (3,895,873)
Ending balance, shares at Dec. 31, 2018 25,229,833      
Ending balance, value at Dec. 31, 2018 $ 25,230 4,688,272 (8,540,053) (3,826,551)
Beginning balance, shares at Mar. 31, 2018 24,671,000      
Beginning balance, value at Mar. 31, 2018 $ 24,661 3,538,341 (5,426,829) (1,863,827)
Stock Based Compensation   $ 114,105   $ 114,105
Stock Grant Program Vesting, shares 137,000 (147)   0
Stock Grant Program Vesting, value $ 147      
Warrants issued related to debt revisions/Warrant Issuance Related to Convertible Debentures/   $ 4,525   $ 4,525
Net loss for period     (499,049) (499,049)
Ending balance, shares at Jun. 30, 2018 24,808,000      
Ending balance, value at Jun. 30, 2018 $ 24,808 3,656,284 (5,925,878) (2,244,246)
Beginning balance, shares at Dec. 31, 2018 25,229,833      
Beginning balance, value at Dec. 31, 2018 $ 25,230 4,688,272 (8,540,053) (3,826,551)
Stock Based Compensation   1,097,137   1,097,137
Stock Options Issued for Loan Term Revisions   17,827   17,827
Stock grants issued for loan term revisions, shares 10,000      
Stock grants issued for loan term revisions, value $ 10 24,090   24,100
Stock Grant Program Vesting, shares 80,800      
Stock Grant Program Vesting, value $ 81 (81)    
Stock Issuance Related to Acquisition, shares 500,000      
Stock Issuance Related to Acquisition, value $ 500 999,500   1,000,000
Warrants issued related to debt revisions/Warrant Issuance Related to Convertible Debentures/   614,041   614,041
Equity value of exercise price associated with convertible debentures   719,479   719,479
Broker warrants associated with issuance of convertible debentures   278,678   278,678
Net loss for period     (2,909,874) (2,909,874)
Ending balance, shares at Jun. 30, 2019 25,820,633      
Ending balance, value at Jun. 30, 2019 $ 25,821 8,438,943 (11,449,927) (2,985,163)
Beginning balance, shares at Mar. 31, 2019 25,749,833      
Beginning balance, value at Mar. 31, 2019 $ 25,750 6,515,229 (10,021,524) (3,480,545)
Stock Based Compensation   508,440   508,440
Stock grants issued for loan term revisions, shares 10,000      
Stock grants issued for loan term revisions, value $ 10 24,090   24,100
Stock Grant Program Vesting, shares 60,800      
Stock Grant Program Vesting, value $ 61 (61)    
Warrants issued related to debt revisions/Warrant Issuance Related to Convertible Debentures/   512,300   512,300
Equity value of exercise price associated with convertible debentures   600,267   600,267
Broker warrants associated with issuance of convertible debentures   278,678   278,678
Net loss for period     (1,428,403) (1,428,403)
Ending balance, shares at Jun. 30, 2019 25,820,633      
Ending balance, value at Jun. 30, 2019 $ 25,821 $ 8,438,943 $ (11,449,927) $ (2,985,163)